A Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite

Completed

Conditions studied: Hernia

In brief

This study will enroll subjects who underwent a laparoscopic ventral hernia repair utilizing Sepramesh at least 12 months before starting in this study. The consented subjects' medical records will be reviewed for evidence of any risk factors of hernia recurrence, procedure time, complications and any documented recurrences. The subjects will be asked to undergo a physical exam to rule out any recurrences that were not documented in the medical records.

Key facts

Study ID

NCT01305473

Run by

C. R. Bard

People needed

90

Starts

2010-08-01

Expected to finish

2011-02-01

Last updated by the study team

2012-08-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have undergone a laparoscopic ventral repair utilizing Sepramesh at least 12 months before starting in this study.
• Have signed an Informed Consent Form (ICF).

You may not qualify if…

• Underwent implantation of Sepramesh for any reason other than ventral hernia repair.

Where it is running

• Cornerstone Medical Center — Centerville, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.